{
  "docId": "019de071-e0d6-76fb-ba84-d69d61ac5ee5",
  "docSlug": "1773642d94b9dc79507cf930970e5456",
  "documentTitle": "Certara | Investor Day Presentation Deck | 91 slides",
  "authorId": "certara",
  "authorName": "Certara",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 40,
  "pageCount": 91,
  "prevPage": 39,
  "nextPage": 41,
  "slideType": "propose_solution",
  "function": "illustrate_case",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "Includes a diagram of PBPK model applications and a specific research highlight for Diclofenac Sodium Topical Gel.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de071-e0d6-76fb-ba84-d69d61ac5ee5/40",
  "deckHref": "/decks/019de071-e0d6-76fb-ba84-d69d61ac5ee5",
  "deckJsonHref": "/decks/019de071-e0d6-76fb-ba84-d69d61ac5ee5.json",
  "deckAnchorHref": "/decks/019de071-e0d6-76fb-ba84-d69d61ac5ee5#slide-40",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.45,
        "x": 0.5,
        "y": 0.215
      },
      "kind": "callout",
      "text": "Milestone FDA Approval of Diclofenac Gel: First complex generic approved using the Simcyp Simulator to establish virtual bioequivalence in lieu of a clinical trial.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a53ee554-ba82-41dd-bbcc-0f0f1617f838",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.4,
        "x": 0.16,
        "y": 0.52
      },
      "kind": "diagram",
      "text": "General PBPK Model Applications for Generic Products",
      "attrs": null,
      "subkind": "hub-spoke",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bc492362-9d93-46bc-8340-876f0b78b955",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.53,
        "y": 0.62
      },
      "kind": "image",
      "text": "Diclofenac Sodium Topical Gel packaging",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1da25f84-cff4-4cb6-be30-a93ac4447334",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.75,
        "y": 0.61
      },
      "kind": "paragraph",
      "text": "Physiologically-based pharmacokinetic modeling supported approval of a locally acting drug based on an efficient alternative bioequivalence approach.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "070be81d-0bc3-406a-9e4b-af76c02f8ec2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.3,
        "x": 0.04,
        "y": 0.23
      },
      "kind": "paragraph",
      "text": "Increasing Access to Generic Alternatives for Complex Drugs: FDA supports the development of generic versions of complex drug products because they represent nearly one-third of drug products currently used but have less generic competition.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "58a3e2d7-df73-48a4-89c2-719c1bc88ddf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.03,
        "y": 0.12
      },
      "kind": "title",
      "text": "Simcyp Simulator can advance development of complex generics",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d5c398cc-8599-45a8-b75d-06ac90dc75bc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "Regulatory priority to increase access to generics",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "676ee052-1500-4dbd-a2c8-34c49c598a4d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "case-study",
      "slug": null,
      "matchId": "930eb0e0-0140-4137-97d9-ba2932498cfb",
      "evidence": "Presentation of FDA approval milestone for Diclofenac Gel",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 40,
      "from": 21,
      "beatId": "3c6ba200-33c0-49d6-af35-b7df7aa31581",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "Certara's solutions and successes are presented",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}